Treviamet®

  • All Products
  • By Generic
  • By Therapeutic Segment

Treviamet®

Therapeutic Segment: Anti-Diabetic

Generic Name: Sitagliptin phosphate monohydrate + Metformin HCI

Indication:

As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus who are already treated with metformin alone or who are not adequately controlled on metformin alone, or for those patients who have initially responded to metformin and require additional glycemic control.

Available as:

Tablets
  • 50MG + 1000MG
  • 50MG + 500MG